# Safety and Efficacy of Arterial Delivery of Autologous Bone Marrow Cells in the Treatment of Insulin-Dependent Diabetes

> **NCT00971503** · PHASE2 · WITHDRAWN · sponsor: **University of Moron** · enrollment: 34 (estimated)

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **PROCEDURE:** autologous bone marrow implantation
- **OTHER:** Saline injection

## Key facts

- **NCT ID:** NCT00971503
- **Lead sponsor:** University of Moron
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-02
- **Primary completion:** 2011-02
- **Final completion:** 2012-02
- **Target enrollment:** 34 (ESTIMATED)
- **Why stopped:** Principal Investigator moved to Chile from Argentina
- **Last updated:** 2011-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00971503

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00971503, "Safety and Efficacy of Arterial Delivery of Autologous Bone Marrow Cells in the Treatment of Insulin-Dependent Diabetes". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00971503. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*